Forget the diagnosis count. The researcher who helped the WHO reframe aging says function, not disease, is the better yardstick.

A new preprint links the company’s cell therapy to less brain inflammation in Alzheimer’s, just as it heads out on an ...

The whole-body scan company is launching a research network with 50+ institutions. Early findings come with some big open ...

The company added hormone therapy to its platform and released IBS results from nearly 16,000 members, with caveats attached. Digbi Health has spent years collecting data on people’s guts. This week ...

All three Phase 3 trials of the weekly shot ribupatide have finished enrolling, and the head-to-head against semaglutide is ...

Patent cliffs and falling R&D productivity push the biggest players toward other people's science – our report puts numbers ...

Monte Rosa’s NEK7-targeting drug pulled several heart-risk biomarkers toward healthy levels in 108 people with obesity.